top of page

Biotech General Discussion

Public·97 members

manny.vacchiano
BPIQ Premium Subscriber

BPIQ Pro

Premium Analyst - Offers a premium marketplace with analysis, portfolios, and more.

Premium Analyst

📌 Key AMGN readouts in 2024

➤ TEZSPIRE: COPD/Ph2 data readout/H1 2024

➤ AMG 786: Obesity/Ph1 data readout/H1 2024

➤ Tarlatamab: Advanced SCLC/PDUFA 6/12/24

➤ Nplate: Chemo-induced thrombocytopenia/Ph3 data readout/H2 2024

➤ TEZSPIRE: Chronic rhinosinusitis w/ nasal polyps/Ph3 data readout/H2 2024

➤ Rocatinlimab: Atopic Dermatitis/Ph3 data readout/H2 2024

➤ UPLIZNA: Myasthenia gravis/Ph3 data readout/H2 2024

➤ UPLIZNA: IgG4-related disease/Ph3 data readout/H2 2024

➤ AMG 670: IPF/Ph2 data readout/H2 2024

➤ MariTide: Obesity/Ph2 data readout/Late 2024


Click link to subscribe to get full access to our catalyst calendar...👇

https://www.bpiq.com/pricing


Article History:

1/30/24 AV


This article is not investment or legal advice.


#AMGN

10 Views
bottom of page